Katrin Tiemann

1.1k total citations
15 papers, 845 citations indexed

About

Katrin Tiemann is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Katrin Tiemann has authored 15 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Katrin Tiemann's work include RNA Interference and Gene Delivery (6 papers), CAR-T cell therapy research (4 papers) and MicroRNA in disease regulation (4 papers). Katrin Tiemann is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), CAR-T cell therapy research (4 papers) and MicroRNA in disease regulation (4 papers). Katrin Tiemann collaborates with scholars based in United States, United Kingdom and Norway. Katrin Tiemann's co-authors include John J. Rossi, John Burnett, Stephen J. Forman, Cy A. Stein, Glen F. Deleavey, Masad J. Damha, Harris S. Soifer, Pritsana Chomchan, Jessica Alluin and Naira E. Souleimanian and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Katrin Tiemann

15 papers receiving 821 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Katrin Tiemann	702	183	108	81	79	15	845
Hassan Dana	571 0.8×	211 1.2×	52 0.5×	136 1.7×	100 1.3×	18	797
Wenxin Cai	773 1.1×	177 1.0×	168 1.6×	104 1.3×	61 0.8×	9	950
Ryan L. Setten	1.1k 1.5×	284 1.6×	105 1.0×	89 1.1×	106 1.3×	10	1.3k
Jeffrey D. McBride	733 1.0×	131 0.7×	51 0.5×	91 1.1×	94 1.2×	51	1000
William Cantley	830 1.2×	165 0.9×	135 1.3×	39 0.5×	97 1.2×	7	964
Chenyu Jiao	720 1.0×	82 0.4×	78 0.7×	66 0.8×	95 1.2×	24	916
Kristi D. Viles	970 1.4×	168 0.9×	101 0.9×	61 0.8×	72 0.9×	12	1.1k
Liu Liang Qin	772 1.1×	154 0.8×	111 1.0×	51 0.6×	102 1.3×	6	893
Dewang Zhou	680 1.0×	132 0.7×	86 0.8×	87 1.1×	78 1.0×	24	940
Eman A. Taha	601 0.9×	201 1.1×	49 0.5×	71 0.9×	100 1.3×	15	726

Countries citing papers authored by Katrin Tiemann

Since Specialization

Citations

This map shows the geographic impact of Katrin Tiemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Tiemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Tiemann more than expected).

Fields of papers citing papers by Katrin Tiemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Tiemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Tiemann. The network helps show where Katrin Tiemann may publish in the future.

Co-authorship network of co-authors of Katrin Tiemann

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Tiemann. A scholar is included among the top collaborators of Katrin Tiemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Tiemann. Katrin Tiemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Budde, Lihua E., John H. Baird, Lu Chen, et al.. (2024). PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease.. Journal of Clinical Oncology. 42(16_suppl). 6534–6534. 1 indexed citations

Budde, Lihua E., John H. Baird, Lu Chen, et al.. (2023). Promising Safety and Anti-Lymphoma Efficacy of Autologous Pmb-CT01 (BAFFRCAR T Cell) Therapy in a First-in-Human Phase 1 Study. Blood. 142(Supplement 1). 221–221. 3 indexed citations

Tiemann, Katrin, Carolina Garri, Sang Bok Lee, et al.. (2018). Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. Oncogene. 38(16). 3003–3018. 28 indexed citations

Tiemann, Katrin, Carolina Garri, Jeffrey Wang, Lauren Clarke, & Kian Kani. (2018). Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays. Journal of Visualized Experiments. 1 indexed citations

Garri, Carolina, Katrin Tiemann, Aleczandria S. Tiffany, et al.. (2018). Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2). Oncotarget. 9(44). 27363–27379. 10 indexed citations

Kani, Kian, Carolina Garri, Katrin Tiemann, et al.. (2017). JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines. Molecular Cancer Therapeutics. 16(8). 1645–1657. 18 indexed citations

Niesen, Michiel J.M., Axel Müller, Katrin Tiemann, et al.. (2016). A Link between Integral Membrane Protein Expression and Simulated Integration Efficiency. Cell Reports. 16(8). 2169–2177. 12 indexed citations

Chavali, Sreenivas, Sören Bruhn, Katrin Tiemann, et al.. (2013). MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases. RNA. 19(11). 1552–1562. 34 indexed citations

Zhou, Jiehua, Katrin Tiemann, Pritsana Chomchan, et al.. (2013). Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Research. 41(7). 4266–4283. 60 indexed citations

10.

Rivera-Gonzalez, Guillermo C., Alastair Droop, Helen J. Rippon, et al.. (2012). Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance. Nucleic Acids Research. 40(11). 4825–4840. 26 indexed citations

11.

Souleimanian, Naira E., Glen F. Deleavey, Harris S. Soifer, et al.. (2012). Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids. Molecular Therapy — Nucleic Acids. 1. e43–e43. 55 indexed citations

12.

Burnett, John, John J. Rossi, & Katrin Tiemann. (2011). Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnology Journal. 6(9). 1130–1146. 353 indexed citations

13.

Tiemann, Katrin, Jessica Alluin, Anja Honegger, et al.. (2011). Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines. Leukemia & lymphoma. 52(11). 2148–2154. 14 indexed citations

14.

Tiemann, Katrin, et al.. (2010). Dual-targeting siRNAs. RNA. 16(6). 1275–1284. 17 indexed citations

15.

Tiemann, Katrin & John J. Rossi. (2009). RNAi‐based therapeutics–current status, challenges and prospects. EMBO Molecular Medicine. 1(3). 142–151. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact